EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY

As of June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY carries a market capitalization of 9.58B, placing it among publicly traded companies globally. Its enterprise value stands at 56.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY has 4.72M shares outstanding.

As of June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY trades at a trailing price-to-earnings ratio of 63.16.

These figures are as of June 30, 2026. EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY trades at an EV/FCF ratio of 0.19, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 56.40M versus a market cap of 9.58B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY maintains a current ratio of 5,098.52, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.98, indicating elevated leverage, while an interest coverage ratio of -0.58 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY posted a return on equity (ROE) of 1.60, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -0.36, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 1.37, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.01, useful for judging operating efficiency across full business cycles.

Over the twelve months ended June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY recorded 13.23M in income tax expense. That works out to an effective tax rate of 8.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 164.99M, leaving 151.76M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 2,036.00, while the 200-day moving average is 2,041.31.

These figures cover the twelve months ended June 30, 2026. EBITDA reached -43.61M, while operating income came in at -43.61M.

As of June 30, 2026, EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY holds 11.06B in cash and equivalents against 1.53B in total debt, resulting in a net debt position of 1.51B. Total book value stands at 9.58B, with working capital of 11.21B providing operational flexibility.

EUGENE SPECIAL PURPOSE ACQUISITION 11 COMPANY produced 220.48M in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 2.33, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt.